Open AccessHepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
Author(s) -
Guichan Liao,
Xueying Ding,
Muye Xia,
Yin Wu,
Hongjie Chen,
Rong Fan,
Xiaoyong Zhang,
Sanjun Cai,
Jie Peng
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s321253
Subject(s) - medicine , hbsag , hbeag , hazard ratio , hepatitis b , gastroenterology , entecavir , seroconversion , post hoc analysis , hepatitis b virus , immunology , virus , lamivudine , confidence interval
It remains unknown how to stratify the risk of clinical relapse of chronic hepatitis B (CHB) patients after stopping nucleos(t)ide analogs (NAs) antiviral therapy.